Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice

British Journal of Cancer

Volumn 70, Issue 1, 1994, Pages 35-41

  Turner, A ^a   King, D J ^a   Farnsworth, A P H ^a   Rhind, S K ^a   Pedley, R B ^b   Boden, J ^b   Boden, R ^b   Millican, T A ^a   Millar, K ^a   Boyce, B ^a   Beeley, N R A ^a   Eaton, M A W ^a   Parker, D ^c  

^a UCB PHARMA   (Belgium)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; CHIMERIC ANTIBODY; INDIUM 111; MACROCYCLIC COMPOUND; PENTETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; COLON; COLON CARCINOMA; DRUG BIOAVAILABILITY; FEMUR; HUMAN; HUMAN TISSUE; LIVER; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

AMINES; ANIMAL; ANTIBODIES, MONOCLONAL; CHELATING AGENTS; CHIMERIC PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; FEMALE; HETEROCYCLIC COMPOUNDS; HUMAN; INDIUM RADIOISOTOPES; LIGANDS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; PENTETIC ACID; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0028235021     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1994.246     Document Type: Article

References (35)

1. ADAIR, J.R. (1992). Engineering antibodies for therapy. Immunol. Rev., 130, 5–40.
2. ANGAL, S., KING, D.J., BODMER, M.W., TURNER, A., LAWSON, A.D.G., ROBERTS, G., PEDLEY, B. & ADAIR, J.R. (1993). A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human IgG4 antibody. Mol. Immunol., 30, 105–108.
3. BEGENT, R.H.J., LEDERMANN, J.A., BAGSHAWE, K.D., GREEN, A.J., KELLY, A.M.B., LANE, D., SECHER, D.S., DEWJI, M.R. & BAKER, T.S. (1990). Phase I/II study of chimeric B72.3 antibody in radioimmunotherapy of colorectal carcinoma. Br. J. Cancer, 62, 487.
4. BRECHBIEL, M.W., GANSOW, O.A., ATCHER, R.W., SCHLOM, J., ESTEBAN, J., SIMPSON, D. & COLCHER, D. (1986). Synthesis of l-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumour imaging studies. Inorg. Chem., 25, 2772–2781.
5. BROAN, C.J., COX, J.P.L., CRAIG, A.S., KATAKY, R., PARKER, D., HARRISON, A., RANDALL, A.M. & FERGUSON, G. (1991). Structure and solution stability of indium and gallium complexes of 1,4,7-triazacyclononanetriacetate and yttrium complexes of 1,4,7,10-tetraazacyclododecanetetraacetate and related ligands. J. Chem. Soc. Perkin Trans., 2, 87–99.
6. lllIn. Cancer Res., 47, 1149–1154.
7. COLCHER, D., KEENAN, A.M., LARSON, S.M. & SCHLOM, J. (1986). Prolonged binding of a radiolabelled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts. Cancer Res., 44, 5744–5751.
8. COLCHER, D., MILENIC, D., ROSELLI, M., RAUBITSCHEK, A., YARRANTON, G., KING, D., ADAIR, J., WHITTLE, N., BODMER, M. & SCHLOM, J. (1989). Characterisation and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. Cancer Res., 49, 1738–1745.
9. COX, J.P.L., JANKOWSKI, K.J., KATAKY, R., PARKER, D., BEELEY, N.R.A., BOYCE, B.A., EATON, M.A.W., MILLAR, K., MILLICAN, T.A., HARRISON, A. & WALKER, C. (1989). Synthesis of a kinetically stable yttrium-90 labelled macrocycle antibody conjugate. J. Chem. Soc., Chem. Common., 12, 797–798.
10. CRAIG, A.S., HELPS, I.A., JANOWSKI, K.J., PARKER, D., BEELEY, N.R.A., BOYCE, B.A., EATON, M.A.W., MILLICAN, T.A., MILLAR, K., PHIPPS, A., RHIND, S.K., HARRISON, A. & WALKER, C. (1989). Towards tumour imaging with Indium-111 labelled macrocycle antibody conjugates. J. Chem. Soc., Chem. Common., 12, 794–796.
11. DAVIDSON, B.R., BABICH, J., YOUNG, H., WADDINGTON, W., CLARKE, G., SHORT, M., BOULOS, P., STYLES, J. & DEAN, C. (1991). The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody. Br. J. Cancer, 64, 850–856.
12. DESHPANDE, S.V., SUBRAMANIAN, R., MCCALL, M.I., DENARDO, S.J., DENARDO, G.L. & MEARES, C. (1990). Metabolism of Indium chelates attached to monoclonal antibody: minimal transchelation of Indium from benzyl-EDTA chelate in vivo. J. Nucl. Med., 31, 218–224.
13. 111In-Cl 10. Nucl. Med. Biol., 18, 705–710.
14. 111In to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts. J. Nucl. Med., 28, 861–870.
15. GOLDENBERG, D.M., WLODKOWSKI, T.J., SHARKEY, R.M., SILBERSTEIN, E.B., SERAFINI, A.N., GARTY, I.I., VAN HEERTUM, R.L., HIGGINBOTHAM-FORD, E.A., KOTLER, J.A., BALASUBRIAMANIAN, N., SWAYNE, L.C., HANSEN, H.J. & PINSKY, C.M. (1993). Colorectal cancer imaging with iodine-123 labelled CEA monoclonal antibody fragments. J. Nucl. Med., 34, 61–70.
16. GRANOWSKA, M., MATHER, S.J. & BRITTON, K.E. (1991). Diagnostic evaluation of 111In and 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer correlations with surgery. Nucl. Med. Biol., 18, 413–424.
17. HARRISON, A., WALKER, C.A., PARKER, D., JANKOWSKI, K.J., COX, J.P.L., CRAIG, A S., SANSOM, J.M., BEELEY, N.R.A., BOYCE, R.A., CHAPLIN, L., EATON, M.A.W., FARNSWORTH, A.P.H., MILLAR, K., MILLICAN, A.T., RANDALL, A.M., RHIND, S.K., SECHER, D.S. & TURNER, A. (1991). The in vivo release of ^ from cyclic and acyclic ligand antibody conjugates. Nucl. Med. Biol., 18, 469–476.
18. HIRD, V., VERHOEYEN, M., BADLEY, R.A., PRICE, D., SNOOK, D., KOSMAS, C., GOODEN, C., BAMIAS, A., MEARES, C., LAVENDER, J.P. & EPPENETOS, A.A. (1991). Tumour localisation with a radioactively labelled reshaped human monoclonal antibody. Br. J. Cancer, 64, 911–914.
19. HNATOWICH, D.J., CHILDS, R.L., LANTEIGNE, D. & NAJAFI, A. (1983). The preparation of DTP A coupled antibodies radiolabelled with metallic radionuclides: an improved method. J. Immunol. Methods, 65, 147–157.
20. HNATOWICH, D.J., GRIFFEN, T.W., KOSCIUCZYK, C., RUSCKOWSKI, M., CHILDS, R.L., MATTIS, J.A., SHEALY, D. & DOCHERTY, P.W. (1985). Pharmacokinetics of an 111In labelled monoclonal antibody in cancer patients. J. Nucl. Med., 26, 849–858.
21. KHAZAELI, M.B., SALEH, M.N., LIU, T.P., MEREDITH, R.F., WHEELER, R.H., BAKER, T.S., KING, D., SECHER, D., ALLEN, L., ROGERS, K., COLCHER, D., SCHLOM, J., SHOCHAT, D. & LOBUGLIO, A.F. (1991). Pharmacokinetics and immune response of 13, I chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in man. Cancer Res., 51, 5461–5466.
22. KING, D.J., MOUNTAIN, A., ADAIR, J R., OWENS, R.J., HARVEY, A., WEIR, N., PROUDFOOT, K.A., PHIPPS, A., LAWSON, A., RHIND, S.K., PEDLEY, B., BODEN, J., BODEN, R., BEGENT, R.H.J., & YARRANTON, G.T. (1992). Tumour localization of engineered antibody fragments. Antibody Immunoconj. Radiopharm., 5, 159–170.
23. KOSMAS, K., SNOOK, D., GOODEN, C.S., COURTENAY-LUCK, N.J., MCCALL, M.J., MEARES, C. & EPPENETOS, A.A. (1992). Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. Cancer Res., 52, 904–911.
24. LAMKI, L.M., BUZDAR, A.U., SINGLETARY, E., ROSENBLUM, M.G., BHADKAMKAR, V., ESPARZA, L., PODOLOFF, D. A., ZUKIWSKI, A., HORTOBAGYI, G.N. & MURRAY, J.L. (1991). Indium-111 labelled B72.3 monoclonal antibody in the detection and staging of breast cancer a phase I study. J. Nucl. Med., 32, 1326–1332.
25. LYONS, A., KING, D.J., OWENS, R.J., YARRANTON, G.T., MILLICAN, T.A., WHITTLE, N.R. & ADAIR, J.R. (1990). Site specific attachment to recombinant antibodies via introduced surface cysteine residues. Protein Eng., 3, 703–708.
26. LUNDY, J., GREINER, J.W. & COCHER, D. (1986). Development of a metastatic human colon cancer xenograft model in the nude mouse. J. Surg. Oncol., 31, 260–267.
27. MEARES, C.F., MCCALL, M.J., REARDON, D.T., GOODWIN, D.A., DIAMANTI, C.I. & MCTIGUE, M. (1984). Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis and subsequent addition of metal ions. Anal. Biochem., 142, 68–78.
28. MEARES, C.F., MOI, M.K., DIRIL, H., KUKIS, D.L., MCCALL, M.J., DESHPANDE, S.V., DENARDO, S.J., SNOOK, D. & EPENETOS, A.A. (1990). Macrocyclic chelates of radiometals for diagnosis and therapy. Br. J. Cancer, 62 (Suppl. X), 21–26.
29. MOI, M.K., MEARES, C.F. & DENARDO, S.J. (1988). The peptide way of macrocyclic bifunctional chelating agents. Synthesis of 2-(p-nitrobenzyl)-1,4,7,10-teracycloododecauie-N, N’, N′, N′″, N″″-tetra -acetic acid, and study of its Yttrium (in) complex. J. Am. Chem. Soc., 110, 6266.
30. PAIK, C.H., HONG, J.J., EBBERT, M.A., HEALD, S.C., REBA, C. & ECKELMAN, W.C. (1985). Relative reactivity of DTP A, immune-reactive antibody-DTPA conjugates and non-immunoreactive antibody-DTPA conjugates toward 11'In. J. Nucl. Med., 26, 482–487.
31. ROSELLI, M., SCHLOM, J., GANSOW, O.A., RAUBITSCHEK, A., MIRZADEH, S., BRECHBIEL, M.W. & COLCHER, D. (1989). Comparative biodistributions of yttrium and indium labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts. J. Nucl. Med. 30, 672–682.
32. SAKAHARA, H., ENDO, K., NAKASHIMA, T., KOIZUMI, M., OHTA, H., TORIZUKA, K., FURUKAWA T., OHMOMO, Y., YOKOYAMA A., OKADA K, YOSHIDA O. A NISHI, S. (1985). Effect of DTPA conjugation on the antigen binding activity and biodistribution of monoclonal antibodies against alpha-feto-protein. J. Nucl. Med., 26, 750–755.
33. SCHUMAKER, J., KLIVENYI, G., MATYS, R., KIRCHGEBNER, H., HAUSER, H., MAIER-BORST, W. & MATZU, S. (1990). Uptake of indium-111 in the liver of mice following administration of indium-111 DTPA-labeled monoclonal antibodies: influence of labeling parameters, physiologic parameters and antibody dose. J. Nucl. Med., 31, 1084–1093.
34. SNOOK, D.E, ROWLINSON-BUSZA, G., MEARES, C. & EPENETOS, A.A. (1991). Indium-111 and yttrium-90 labelled macrocyclic chelating agents. In Monoclonal Antibodies, Epenetos A.A. (ed.) pp. 157-166. Chapman & Hall: London.
35. WHITTLE, N., ADAIR, J., LLOYD, C., JENKINS, L., DEVINE, J., SCHLOM, J., RAUBITSCHEK, A., COLCHER, D. & BODMER, M. (1987). Expression in COS cells of a mouse-human chimaeric B72.3 antibody. Protein Eng., 1, 499–505.